Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Mexico Health Reporter.
Press releases published on September 15, 2025
Descartes’ 9th Annual Study Finds Transportation Management Reaches Record Strategic Importance
81% of shippers and logistics services providers view transportation as a competitive weapon; growth and AI adoption driving investments despite automation gap LONDON and ATLANTA, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq:DSGX) ( …
Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea
Upfront fees and near-term development milestone payments totaling up to $7.5 million Potential sales milestones of $180 million or more in first 10 years of commercialization Royalties equaling 25% of net sales Ocugen to manufacture and supply OCU400 …
Soleo Health Promotes Holly Flax to Chief Operating Officer
FRISCO, Texas, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today the promotion of Holly Flax to the post of chief operating officer. Flax joined Soleo in 2014 …
Philips intends to extend maturity of forward purchases of 4 million shares for long-term incentive plans
September 15, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) announces today that it intends to extend the settlement of two forward contracts for 2 million long-term incentive plans shares each as part of the share repurchase …
The 2025 First VPR Clinical Academic Exchange Conference and Global Launch Conference concluded successfully
BEIJING, Sept. 15, 2025 (GLOBE NEWSWIRE) -- On September 3, 2025, the "2025 New Technology Symposium on Retinal Peripheral Vision and the First VPR Clinical Academic Exchange Conference" was held in Hangzhou, hosted by Chinese Association of …
Successful Commercial Launch of Ryoncil® Highlighted at Global Healthcare Conferences
NEW YORK, Sept. 14, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced that the successful commercial launch of Ryoncil® (remestemcel-L-rknd), the only …